Frank J. Connor

There was a trend toward a reduction in mortality in patients with COPD who received beta-blocker treatment compared with patients who did not.

Vasopressor requirement, transfusions, neurologic dysfunction, coagulopathy, and acute respiratory distress syndrome were related to higher mortality after multivariate analysis.

Vitamin C was associated with lower mortality rates, shorter lengths of ICU stay, and shorter durations of vasopressor use in patients with sepsis.